Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Danish pharmaceutical giant Novo Nordisk cuts sales and profit forecasts for second time amid intensifying competition in weight-loss drug market.
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
As slimming injections surge in popularity, fitness centres report booming business from users fighting to preserve muscle mass while shedding pounds
Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.
University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.
Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.
Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Groundbreaking obesity medication Wegovy gains Medicaid coverage across multiple American states, marking a significant shift in healthcare policy for weight management treatments.
High street pharmacy chain Boots has suspended its popular 'fat jab' weight loss injection service following overwhelming demand and supply shortages, leaving thousands of customers seeking alternatives.
Groundbreaking research reveals popular weight-loss drugs Ozempic and Wegovy are causing dangerous stomach complications during medical scans, prompting urgent NHS warnings.
Groundbreaking research reveals GLP-1 medications prescribed for weight management are showing unexpected benefits in reducing alcohol consumption among users, with some reporting complete loss of interest in drinking.
A leading neurologist reveals how excessive phone use is creating digital dementia and silent strokes - discover the shocking symptoms and how to protect your brain health.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
Groundbreaking medical imaging uncovers alarming side effects of popular weight-loss drugs Ozempic and Wegovy that patients need to know about.
Groundbreaking research reveals GLP-1 agonists like Ozempic and Wegovy may cause misleading results on CT and PET scans, potentially hiding cancers and leading to dangerous misdiagnoses.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Warehouse giant Costco is now offering substantial discounts on popular weight loss medications Ozempic and Wegovy, making groundbreaking treatments more accessible to consumers across the UK.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.